KTTA Stock Price History and Quote Analysis: Insights for Investors
Pasithea Therapeutics Corp.
Stock Price Today
Pasithea Therapeutics Corp. (KTTA) stock declined over -1.44%, trading at $5.12 on NASDAQ, down from the previous close of $5.19. The stock opened at $5.09, fluctuating between $5.09 and $5.13 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida.
Company Information
| Employees | 8 |
| Beta | 0.742 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Pasithea Therapeutics Corp. (NASDAQ: KTTA) stock price is $5.12 in the last trading session. During the trading session, KTTA stock reached the peak price of $5.13 while $5.09 was the lowest point it dropped to. The percentage change in KTTA stock occurred in the recent session was -1.44% while the dollar amount for the price change in KTTA stock was -$0.08.
The NASDAQ listed KTTA is part of Biotechnology industry that operates in the broader Healthcare sector. Pasithea Therapeutics Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Prof. Lawrence Steinman BA, M.D.
Executive Chairman & Co-Founder
Dr. Lawrence Steinman BA, M.D.
Executive Chairman & Co-Founder
Dr. Tiago Reis Marques M.D., Ph.D.
Chief Executive Officer & Director
Dr. Yassine Bendiabdallah Ph.D.
Chief Operating Officer & Head of UK Clinics
Prof. Lawrence Steinman BA, M.D., Ph.D.
Executive Chairman & Co-Founder
Dr. Graeme Currie Ph.D.
Chief Devel. Officer
Dr. Lawrence Steinman BA, M.D., Ph.D.
Co-Founder & Executive Co-Chairman
Dr. Tiago Reis Marques
Chief Executive Officer & Director
Mr. Daniel H. Schneiderman
Chief Financial Officer
KTTA's closing price is 44.99% higher than its 52-week low of $3.61 where as its distance from 52-week high of $17.40 is -69.92%.
Number of KTTA employees currently stands at 8.
Official Website of KTTA is: https://www.pasithea.com
KTTA could be contacted at phone 702 514 4174 and can also be accessed through its website. KTTA operates from 1111 Lincoln Road, Miami Beach, FL 33139, United States.
KTTA stock volume for the day was 2.03K shares. The average number of KTTA shares traded daily for last 3 months was 930.33K.
The market value of KTTA currently stands at $5.34M with its latest stock price at $5.12 and 1.04M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com